Ethyl loflazepate (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ethyl loflazepate" in English language version.

refsWebsite

Global rank English rank

12nih.gov

4^th place

7doi.org

2^nd place

3web.archive.org

1^st place

2semanticscholar.org

11^th place

8^th place

1in.gov.br

3,151^st place

5,932^nd place

1espacenet.com

800^th place

676^th place

1non-benzodiazepines.org.uk

low place

1saludzac.gob.mx

low place

1famguerra.com

low place

doi.org

Ba BB, Iliadis A, Cano JP (1989). "Pharmacokinetic modeling of ethyl loflazepate (Victan) and its main active metabolites". Annals of Biomedical Engineering. 17 (6): 633–646. doi:10.1007/BF02367467. PMID 2574017. S2CID 31310535.
Ueki S, Watanabe S, Yamamoto T, Shibata S, Shibata K, Ohta H, et al. (November 1983). "[Behavioral effects of ethyl loflazepate and its metabolites]". Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica. 82 (5): 395–409. doi:10.1254/fpj.82.395. PMID 6142848.
Cautreels W, Jeanniot JP (November 1980). "Quantitative analysis of CM 6912 (ethyl loflazepate) and its metabolites in plasma and urine by chemical ionization gas chromatography mass spectrometry. Application to pharmacokinetic studies in man". Biomedical Mass Spectrometry. 7 (11–12): 565–571. doi:10.1002/bms.1200071124. PMID 6112027.
Sakai Y, Namima M (April 1985). "Inhibitory effect on 3H-diazepam binding and potentiating action on GABA of ethyl loflazepate, a new minor tranquilizer". Japanese Journal of Pharmacology. 37 (4): 373–379. doi:10.1254/jjp.37.373. PMID 2861304.
Ba BB, Iliadis A, Durand A, Berger Y, Necciari J, Cano JP (1989). "Effect of renal failure on the pharmacokinetics of ethyl loflazepate (Victan) in man". Fundamental & Clinical Pharmacology. 3 (1): 11–17. doi:10.1111/j.1472-8206.1989.tb00025.x. PMID 2714728. S2CID 2850707.
Kamijo Y, Hayashi I, Nishikawa T, Yoshimura K, Soma K (March 2005). "Pharmacokinetics of the active metabolites of ethyl loflazepate in elderly patients who died of asphyxia associated with benzodiazepine-related toxicity". Journal of Analytical Toxicology. 29 (2): 140–144. doi:10.1093/jat/29.2.140. PMID 15902983.
Imanishi T, Onozawa K, Hayashi A, Baba J (December 2001). "[Effects of fluvoxamine on both the desired anxiolytic effect and the adverse motor incoordination and amnesia induced by benzodiazepines]". Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica. 118 (6): 403–410. doi:10.1254/fpj.118.403. PMID 11778459.

espacenet.com

worldwide.espacenet.com

DE 2012190

famguerra.com

"VICTAN". Farmacia Guerra. Retrieved 2009-12-25.

in.gov.br

Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.

nih.gov

pubmed.ncbi.nlm.nih.gov

Ba BB, Iliadis A, Durand A, Berger Y, Cano JP (October 1988). "New approach in bioavailability study of two formulations of ethyl loflazepate". Arzneimittel-Forschung. 38 (10): 1486–1489. PMID 2904268.
Ba BB, Iliadis A, Cano JP (1989). "Pharmacokinetic modeling of ethyl loflazepate (Victan) and its main active metabolites". Annals of Biomedical Engineering. 17 (6): 633–646. doi:10.1007/BF02367467. PMID 2574017. S2CID 31310535.
Ueki S, Watanabe S, Yamamoto T, Shibata S, Shibata K, Ohta H, et al. (November 1983). "[Behavioral effects of ethyl loflazepate and its metabolites]". Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica. 82 (5): 395–409. doi:10.1254/fpj.82.395. PMID 6142848.
Mazue G, Berthe J, Newmann AJ, Brunaud M (October 1981). "A toxicologic evaluation of ethyl fluclozepate (CM 6912)". International Journal of Clinical Pharmacology, Therapy, and Toxicology. 19 (10): 453–472. PMID 6116677.
Cautreels W, Jeanniot JP (November 1980). "Quantitative analysis of CM 6912 (ethyl loflazepate) and its metabolites in plasma and urine by chemical ionization gas chromatography mass spectrometry. Application to pharmacokinetic studies in man". Biomedical Mass Spectrometry. 7 (11–12): 565–571. doi:10.1002/bms.1200071124. PMID 6112027.
Sakai Y, Namima M (April 1985). "Inhibitory effect on 3H-diazepam binding and potentiating action on GABA of ethyl loflazepate, a new minor tranquilizer". Japanese Journal of Pharmacology. 37 (4): 373–379. doi:10.1254/jjp.37.373. PMID 2861304.
Chambon JP, Perio A, Demarne H, Hallot A, Dantzer R, Roncucci R, Bizière K (1985). "Ethyl loflazepate: a prodrug from the benzodiazepine series designed to dissociate anxiolytic and sedative activities". Arzneimittel-Forschung. 35 (10): 1573–1577. PMID 2866771.
Davi H, Guyonnet J, Sales Y, Cautreels W (1985). "Metabolism of ethyl loflazepate in the rat, the dog, the baboon and in man". Arzneimittel-Forschung. 35 (7): 1061–1065. PMID 2864933.
Ba BB, Iliadis A, Durand A, Berger Y, Necciari J, Cano JP (1989). "Effect of renal failure on the pharmacokinetics of ethyl loflazepate (Victan) in man". Fundamental & Clinical Pharmacology. 3 (1): 11–17. doi:10.1111/j.1472-8206.1989.tb00025.x. PMID 2714728. S2CID 2850707.
Pulce C, Mollon P, Pham E, Frantz P, Descotes J (April 1992). "Acute poisonings with ethyle loflazepate, flunitrazepam, prazepam and triazolam in children". Veterinary and Human Toxicology. 34 (2): 141–143. PMID 1354907.
Kamijo Y, Hayashi I, Nishikawa T, Yoshimura K, Soma K (March 2005). "Pharmacokinetics of the active metabolites of ethyl loflazepate in elderly patients who died of asphyxia associated with benzodiazepine-related toxicity". Journal of Analytical Toxicology. 29 (2): 140–144. doi:10.1093/jat/29.2.140. PMID 15902983.
Imanishi T, Onozawa K, Hayashi A, Baba J (December 2001). "[Effects of fluvoxamine on both the desired anxiolytic effect and the adverse motor incoordination and amnesia induced by benzodiazepines]". Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica. 118 (6): 403–410. doi:10.1254/fpj.118.403. PMID 11778459.

non-benzodiazepines.org.uk

"Benzodiazepine Names". non-benzodiazepines.org.uk. Archived from the original on 2008-12-08. Retrieved 2009-04-05.

saludzac.gob.mx

"Victan". saludzac.gob.mx/. Archived from the original on 2009-05-26. Retrieved 2009-12-25.

semanticscholar.org

api.semanticscholar.org

Ba BB, Iliadis A, Cano JP (1989). "Pharmacokinetic modeling of ethyl loflazepate (Victan) and its main active metabolites". Annals of Biomedical Engineering. 17 (6): 633–646. doi:10.1007/BF02367467. PMID 2574017. S2CID 31310535.
Ba BB, Iliadis A, Durand A, Berger Y, Necciari J, Cano JP (1989). "Effect of renal failure on the pharmacokinetics of ethyl loflazepate (Victan) in man". Fundamental & Clinical Pharmacology. 3 (1): 11–17. doi:10.1111/j.1472-8206.1989.tb00025.x. PMID 2714728. S2CID 2850707.

web.archive.org

Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
"Benzodiazepine Names". non-benzodiazepines.org.uk. Archived from the original on 2008-12-08. Retrieved 2009-04-05.
"Victan". saludzac.gob.mx/. Archived from the original on 2009-05-26. Retrieved 2009-12-25.